MBP and myeloid sarcoma: Abzymes specifically hydrolyze myelin basic protein (MBP), but not other control proteins revealed in the blood of patients with multiple sclerosis (MS) [13,14,15], systemic lupus erythematosus (SLE) [19,20,21], and schizophrenia [22].